Cargando…
A rare cutaneous manifestation of immune checkpoint inhibitor therapy
Leukocytoclastic vasculitis can be an uncommon and/or underreported adverse event of immune checkpoint inhibitor therapy, an established cancer treatment option. Differentiation among other cutaneous manifestations of adverse medication reactions—such as Stevens–Johnson syndrome, erythema multiforme...
Autores principales: | Cherneskie, John, Tuan, Alyssa, Corey, Zachary, Polimera, Hyma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067804/ https://www.ncbi.nlm.nih.gov/pubmed/37020667 http://dx.doi.org/10.1002/ccr3.7151 |
Ejemplares similares
-
Immune mediated necrotizing myopathy: A rare complication of statin therapy
por: Abusharar, Shady Piedra, et al.
Publicado: (2020) -
Cutaneous manifestations associated with immune checkpoint inhibitors
por: Watanabe, Tomoya, et al.
Publicado: (2023) -
Muir-Torre Syndrome, a Rare Phenotype of Hereditary Nonpolyposis Colorectal Cancer With Cutaneous Manifestations
por: Rubay, David, et al.
Publicado: (2019) -
Metastasis of Ewing Sarcoma to the Pancreas: Case Report and Literature Review
por: Polimera, Hyma, et al.
Publicado: (2020) -
A Case of Confirmed Ceftriaxone-induced Immune Thrombocytopenia
por: Piedra Abusharar, Shady, et al.
Publicado: (2019)